Real Estate [ 12/12 ] | Diversified REITs [ 63/74 ]
NYSE | Common Stock
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
With our founding in 1994, Alexandria pioneered the life science real estate niche.
Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
As of March 31, 2025, Alexandria has a total market capitalization of 28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction.
Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success.
Alexandria also provides strategic capital to transformative life science companies through our venture capital platform.
We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 21, 25 | 0.51 Decreased by -47.40% | 0.60 Decreased by -15.52% |
| Jan 27, 25 | 0.69 Increased by +227.78% | 0.90 Decreased by -22.99% |
| Oct 21, 24 | 0.96 Increased by +638.46% | 0.90 Increased by +6.67% |
| Jul 22, 24 | 0.25 Decreased by -50.98% | 0.80 Decreased by -68.75% |
| Apr 22, 24 | 0.97 Increased by +120.45% | 0.81 Increased by +19.75% |
| Jan 29, 24 | -0.54 Decreased by -274.19% | 0.56 Decreased by -196.43% |
| Oct 23, 23 | 0.13 Decreased by -93.84% | 1.14 Decreased by -88.60% |
| Jul 24, 23 | 0.51 Decreased by -69.46% | 0.64 Decreased by -20.31% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 758.16 M Decreased by -1.42% | -11.60 M Decreased by -106.80% | Decreased by -1.53% Decreased by -106.90% |
| Dec 31, 24 | 112.69 M Decreased by -85.12% | -62.24 M Decreased by -115.91% | Decreased by -55.24% Decreased by -206.92% |
| Sep 30, 24 | 775.74 M Increased by +8.68% | 164.67 M Increased by +578.54% | Increased by +21.23% Increased by +524.34% |
| Jun 30, 24 | 766.73 M Increased by +7.40% | 46.70 M Increased by +179.69% | Increased by +6.09% Increased by +160.41% |
| Mar 31, 24 | 769.11 M Increased by +9.75% | 170.54 M Increased by +420.73% | Increased by +22.17% Increased by +374.48% |
| Dec 31, 23 | 757.22 M Increased by +12.97% | 391.19 M Increased by +403.16% | Increased by +51.66% Increased by +345.40% |
| Sep 30, 23 | 713.79 M Increased by +8.17% | 24.27 M Decreased by -92.96% | Increased by +3.40% Decreased by -93.49% |
| Jun 30, 23 | 713.90 M Increased by +10.89% | 16.70 M Decreased by -93.87% | Increased by +2.34% Decreased by -94.47% |